Dangerous 'Barbie drug' Melanotan-II sparks crackdown on social media influencers Mon 5 Dec 2022 at 12:01pm Authorities are warning about a product dubbed the "Barbie drug" that promises to give users a tan without the sun, but can have serious side effects including, in rare cases, melanoma
People are NOT choosing to have obesity
Because Rybelsus slows down how quickly food leaves the stomach, the most common adverse reactions reported with Rybelsus were gastrointestinal and included (Novo Nordisk, 2021): Nausea Stomach pain Diarrhea Decreased appetite Vomiting Constipation Other less common but potentially serious side effects include: Risk of thyroid tumors Pancreatitis Complications in people with diabetic eye disease Low blood sugar (when used with insulin or other medications that lower blood sugar) Kidney disease Allergic reactions Dosage Rybelsus comes as oral tablets available in 3 mg, 7 mg, and 14 mg doses
Some of the brand names: Wegovy, Ozempic, Zepbound, Mounjaro
The identification of subgroups that are most likely to benefit from GLP-1RAs could be guided by biomarkers, and cardiac imaging may help determine whether the advantages of GLP-1RAs extend beyond the metabolic or obesity phenotypes
.png.jpg)
